US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

BriaCell Therapeutics Corp.

4.46

-0.1300-2.83%

Post-market: 4.41-0.0500-1.12%16:15 EDT

Volume:441.33K

Turnover:1.93M

Market Cap:30.22M

PE:-0.64

High:4.56

Open:4.50

Low:4.04

Close:4.59

Loading ...

Overview Company News Filings

BriaCell presents preclinical data from Phase 3 study of Bria-IMT

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

BriaCell Therapeutics Closes $13.8 Million Public Offering

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

Wall Street Set to Open Lower Friday Amid Slew of Earnings Reports

MT Newswires Live

BriaCell Therapeutics to Raise $13.8 Million in Public Offering; Shares Fall

MT Newswires Live

BriaCell Therapeutics Announces $13.8 Million Public Offering

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

BriaCell Jumps 41% in U.S. Pre-market Trading, Reports Complete Lung Metastasis Resolution in Patient

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

BriaCell Therapeutics: Promising Phase 3 Trial Progress and Strategic Financial Management Justify Buy Rating

BriaCell announces ongoing Phase 3 study enrolled over 75 patients

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

BriaCell Therapeutics Stock Rises on Data for Late Stage Breast Cancer Treatment

BriaCell Says Breast Cancer Therapy Shows Positive Survival Data; Shares Rise

MT Newswires Live

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3

BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BCTX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BCTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCTX\",,,,,undefined,":{"symbol":"BCTX","market":"US","secType":"STK","nameCN":"BriaCell Therapeutics Corp.","latestPrice":4.46,"timestamp":1746043200000,"preClose":4.59,"halted":0,"volume":441333,"hourTrading":{"tag":"盘后","latestPrice":4.41,"preClose":4.46,"latestTime":"16:15 EDT","volume":419,"amount":1858.4900030000001,"timestamp":1746044143151},"delay":0,"floatShares":6265900,"shares":6776100,"eps":-6.919462,"marketStatus":"Post-Mkt","change":-0.13,"latestTime":"04-30 16:16:02 EDT","open":4.5,"high":4.56,"low":4.0406,"amount":1933151.521248,"amplitude":0.113159,"askPrice":4.43,"askSize":1,"bidPrice":4.4,"bidSize":1,"shortable":0,"etf":0,"ttmEps":-6.919462,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746057600000},"marketStatusCode":4,"adr":0,"listingDate":1614142800000,"exchange":"NASDAQ","adjPreClose":4.59,"preHourTrading":{"tag":"盘前","latestPrice":4.57,"preClose":4.59,"latestTime":"09:28 EDT","volume":46423,"amount":213993.6101849,"timestamp":1746019710170},"postHourTrading":{"tag":"盘后","latestPrice":4.41,"preClose":4.46,"latestTime":"16:15 EDT","volume":419,"amount":1858.4900030000001,"timestamp":1746044143151},"volumeRatio":0.045039,"impliedVol":0.6054,"impliedVolPercentile":0.2032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BCTX\",,,,,undefined,":{"symbol":"BCTX","floatShares":6265900,"roa":"-158.14%","roe":"-536.81%","lyrEps":-4.367806,"volumeRatio":0.045039,"shares":6776100,"dividePrice":0,"high":4.56,"amplitude":0.113159,"preClose":4.59,"low":4.0406,"week52Low":3,"pbRate":"8.39","week52High":36.6,"institutionHeld":0,"latestPrice":4.46,"eps":-6.919462,"divideRate":0,"volume":441333,"delay":0,"ttmEps":-6.919462,"open":4.5,"prevYearClose":8.475,"prevWeekClose":5.2,"prevMonthClose":3.65,"prevQuarterClose":3.65,"fiveDayClose":5.43,"twentyDayClose":3.47,"sixtyDayClose":5.04},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BCTX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2531036140","title":"BriaCell presents preclinical data from Phase 3 study of Bria-IMT","url":"https://stock-news.laohu8.com/highlight/detail?id=2531036140","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531036140?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:36","pubTimestamp":1746013004,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics is presenting clinical data from the Phase 3 study of its product candidate, Bria-IMT, in metastatic breast cancer sup...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-presents-preclinical-data-from-phase-3-study-of-bria-imt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-presents-preclinical-data-from-phase-3-study-of-bria-imt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"gpt_icon":0},{"id":"2531303571","title":"BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified","url":"https://stock-news.laohu8.com/highlight/detail?id=2531303571","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531303571?lang=en_us&edition=fundamental","pubTime":"2025-04-30 19:30","pubTimestamp":1746012600,"startTime":"0","endTime":"0","summary":"Phase 3 clinical data shows potential predictive biomarkers for treatment response, first identified in Phase 2 study. Biomarkers could be utilized to predict and provide better patient outcomes, including response rates and survival benefits. Positive delayed-type hypersensitivity   and a favorable Neutrophil-to-Lymphocyte Ratio   linked to longer progression-free survival  in Phase 3 patients. Presence of Circulating Tumor Cells  after patients’ initial Phase 3 treatment supports role as negative prognostic marker . Bria-IMT Phase 3 regimen was well-tolerated with a preferred tolerability profile. “Using biomarkers as powerful instruments to predict patient responsiveness to the Bria-IMT treatment would allow physicians and oncologists to identify potential responders sooner, providing better clinical outcomes and ultimately extending patients’ lives,” stated Carmen Calfa, MD, Clinical Research Lead for the breast site disease group at the University of Miami Miller School of Medicin","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-reports-breaker-phase-3-113000083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","BCTXW","BCTXZ","BK4097","BK4211","BK4606","NLR","PFS","BCTX","BK4129","BK4195","CAML","OS","TPC","DTH"],"gpt_icon":0},{"id":"2531266324","title":"BriaCell Therapeutics Closes $13.8 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2531266324","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531266324?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:39","pubTimestamp":1745872746,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics ( ($TSE:BCT) ) just unveiled an update. BriaCell Therapeutics has successfully closed a public offering, raising approximatel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-closes-13-8-million-public-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-closes-13-8-million-public-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2531263564","title":"BriaCell Therapeutics Announces Closing of $13.8 million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2531263564","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531263564?lang=en_us&edition=fundamental","pubTime":"2025-04-29 04:05","pubTimestamp":1745870700,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, April 28, 2025  -- BriaCell Therapeutics Corp.   , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the closing of its previously announced underwritten public offering of 3,066,666 units, including 399,999 units sold upon the full exercise of the underwriter’s option to purchase additional units. Each unit consists of one common share  and one warrant . Each unit was sold to the public at a price of $4.50 per unit  for gross proceeds of approximately $13.8 million, before deducting underwriting discounts and offering expenses. The Warrants included in the units were approved for listing on the Nasdaq Capital Market and commenced trading under the symbol “BCTXZ” on April 25, 2025. Each Warrant is immediately exercisable, entitles the holder to purchase one common share at an exercise price of $5.25 per share and expires five years from the date of issuance. The Company is r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-therapeutics-announces-closing-13-200500270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCTX","LENZ","BK4139","BCTXW","BK4007","BCTXZ"],"gpt_icon":0},{"id":"2530147098","title":"BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2530147098","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530147098?lang=en_us&edition=fundamental","pubTime":"2025-04-28 19:30","pubTimestamp":1745839800,"startTime":"0","endTime":"0","summary":"Overall survival and clinical benefit in Phase 2 continue to outperform historical benchmarks, including very heavily pretreated patients. Clinical benefit observed in 83% of evaluable patient sub-group treated with the phase 3 formulation. Improved new Bria-OTS+ platform provides powerful innate and adaptive immune system activation. Title:Survival outcomes in a randomized phase 2 ofBria-IMT: An allogeneic whole cell cancer vaccineSession Title:Phase II and Phase III Clinical TrialsSession Start:4/28/2025 2:00 PM – 5:00 PM CSTLocation:Poster Section 50Poster Board Number:18Abstract Presentation Number:CT100. “We are thrilled to share impressive survival and clinical efficacy data at AACR on the advantages of using Bria-IMT plus checkpoint inhibitor in heavily treated patients who have failed multiple prior treatments, including ADCs and CPIs,” stated lead author, Saranya Chumsri, MD, Principal Investigator and Professor of Oncology, Mayo Clinic. “Treatment options have been limited fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-presents-benchmark-beating-survival-113000613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCTX","OS","BK4139","BCTXW","ORR","BCTXZ","BK4097"],"gpt_icon":0},{"id":"2530613504","title":"Wall Street Set to Open Lower Friday Amid Slew of Earnings Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2530613504","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530613504?lang=en_us&edition=fundamental","pubTime":"2025-04-25 21:18","pubTimestamp":1745587126,"startTime":"0","endTime":"0","summary":"Group  lost 19%, eating half of Thursday's 38% gain.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BCTX","OMEX","INTS","SES","PONY","CIA","SAIA","PET"],"gpt_icon":1},{"id":"2530180487","title":"BriaCell Therapeutics to Raise $13.8 Million in Public Offering; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2530180487","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530180487?lang=en_us&edition=fundamental","pubTime":"2025-04-25 20:36","pubTimestamp":1745584619,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics  said Friday it priced a public offering of 3.07 million units at $4.50 each, to raise gross proceeds of about $13.8 million.Each unit includes one common share and one warrant to buy another share at $5.25, exercisable immediately and valid for five years, the company said.The warrants will begin trading on Nasdaq under the ticker \"BCTXZ\" on Friday, the company said, adding the offering is expected to close on Monday, with proceeds going toward working capital and general corporate purposes.BriaCell shares were down more than 21% in premarket trading.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BCTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2530119509","title":"BriaCell Therapeutics Announces $13.8 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2530119509","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530119509?lang=en_us&edition=fundamental","pubTime":"2025-04-25 08:40","pubTimestamp":1745541613,"startTime":"0","endTime":"0","summary":"An update from BriaCell Therapeutics ( ($TSE:BCT) ) is now available. BriaCell Therapeutics has announced the pricing of a $13.8 million public off...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-announces-13-8-million-public-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-therapeutics-announces-13-8-million-public-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BCTX","BK4007"],"gpt_icon":0},{"id":"2530163559","title":"BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2530163559","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530163559?lang=en_us&edition=fundamental","pubTime":"2025-04-25 08:00","pubTimestamp":1745539200,"startTime":"0","endTime":"0","summary":"PHILADELPHIA and VANCOUVER, British Columbia, April 24, 2025  -- BriaCell Therapeutics Corp.   , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced the pricing of an underwritten public offering of 3,066,666 units, including 399,999 units sold upon the full exercise of the underwriter’s option to purchase additional units. Each unit consists of one common share  and one warrant . Each unit is being sold to the public at a price of $4.50 per unit  for gross proceeds of approximately $13.8 million, before deducting underwriting discounts and offering expenses. The Warrants included in the units have been approved for listing on the Nasdaq Capital Market and are expected to commence trading under the symbol “BCTXZ” on April 25, 2025. Each Warrant is immediately exercisable, and will entitle the holder to purchase one common share at an exercise price of $5.25 per share and will expire five years from the date of issuance. T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-therapeutics-announces-pricing-13-000000540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BCTX","LENZ","BK4139","BCTXW"],"gpt_icon":0},{"id":"2529980343","title":"BriaCell Jumps 41% in U.S. Pre-market Trading, Reports Complete Lung Metastasis Resolution in Patient","url":"https://stock-news.laohu8.com/highlight/detail?id=2529980343","media":"MT Newswires","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529980343?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:43","pubTimestamp":1745498625,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics , up 41% in U.S. pre-market trading, on Thursday confirmed the sustained complete resolution of the lung metastasis, first reported in February, two months after initial treatment.The latest data at four months also demonstrates stable disease elsewhere, the company said.The patient, a 78-year-old woman with metastatic breast cancer, had failed several prior lines of therapy and received the lowest dose level in the Phase 1/2a Bria-OTS study. At enrollment last November, she had extensive metastases including bone, lymph node and lung involvement. Following Bria-OTS injections every two weeks for six weeks, and subsequent dosing every three weeks, the lung metastasis completely resolved with stable disease elsewhere. This response is now confirmed and shows the potentially promising activity of the Bria-OTS platform as monotherapy, Briacell said.\"This unprecedented anti-cancer response in the first patient dosed with Bria-OTS is an important milestone for us and p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-jumps-41-u-pre-124345885.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BriaCell Jumps 41% in U.S. Pre-market Trading, Reports Complete Lung Metastasis Resolution in Patient","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCTX","BK4139","BCTXW"],"gpt_icon":0},{"id":"2529983362","title":"BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™","url":"https://stock-news.laohu8.com/highlight/detail?id=2529983362","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529983362?lang=en_us&edition=fundamental","pubTime":"2025-04-24 19:30","pubTimestamp":1745494200,"startTime":"0","endTime":"0","summary":" Complete resolution of lung metastasis confirmed at 4 month follow-up in hormone receptor positive (HR+) breast cancer patient. Treatment well-tolerated and patient remains on study with stable disease elsewhere. Sustained clinical response supports Bria-OTS personalized, off-the-shelf immunotherapy approach in Phase 1/2a metastatic breast cancer study. PHILADELPHIA and VANCOUVER, British Columbia, April 24, 2025  -- BriaCell Therapeutics Corp.   , a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, confirms the sustained complete resolution of the lung metastasis, first reported in February 2025, two months after initial treatment in the ongoing Phase 1/2 Bria-OTS study. The latest data at four months also demonstrates stable disease elsewhere.Figure 1: Treatment with Bria-OTS monotherapy resulted in 100% resolution of tumor in the lung of the metastatic breast cancer  patient following 2 months of therapy and confirmed at 4 months of the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-confirms-100-resolution-lung-113000825.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCTXW","MBC","BCTX","BK4139","BK4086"],"gpt_icon":0},{"id":"2529050530","title":"Why Vertiv Holdings Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2529050530","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529050530?lang=en_us&edition=fundamental","pubTime":"2025-04-23 19:01","pubTimestamp":1745406097,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/44945232/why-vertiv-holdings-shares-are-trading-higher-by-17-here-are-20-stocks-moving-premarket","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSYW.SI","BK4543","AGMH","QID","ENPH","NG","BK4118","NDRA","PEGA","BK4588","IE00BMPRXR70.SGD","LU2506951792.HKD","PSQ","VRT","SEDG",".IXIC","AGRI","MNQmain","LU2357305700.SGD","IE00BN0W2T93.GBP","FRGE","USJW.SI","LU1548497426.USD","SQQQ","BK4147","BK4212","TQQQ","USAW.SI","BTOG","BK4082","NTHI","BK4094","QLD","BK4519","SNOA","JYD","BGI","ETNB","NQmain","NVIW.SI","BK4112","LU0823414478.USD","BCTX","LU1093756325.SGD","BK4139","GAIA","MRIN"],"gpt_icon":1},{"id":"2529339195","title":"BriaCell Therapeutics: Promising Phase 3 Trial Progress and Strategic Financial Management Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2529339195","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529339195?lang=en_us&edition=fundamental","pubTime":"2025-04-22 23:05","pubTimestamp":1745334313,"startTime":"0","endTime":"0","summary":"Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on BriaCell Therapeutics (BCT – Research Report), retaining the price target of $32...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/briacell-therapeutics-promising-phase-3-trial-progress-and-strategic-financial-management-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/briacell-therapeutics-promising-phase-3-trial-progress-and-strategic-financial-management-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","PRGS","BCTX"],"gpt_icon":0},{"id":"2529705083","title":"BriaCell announces ongoing Phase 3 study enrolled over 75 patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2529705083","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529705083?lang=en_us&edition=fundamental","pubTime":"2025-04-22 19:37","pubTimestamp":1745321840,"startTime":"0","endTime":"0","summary":"BriaCell (BCTX) Therapeutics announces that its ongoing Phase 3 clinical study has consented over 100 and has enrolled over 75 patients. BriaCell a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/briacell-announces-ongoing-phase-3-study-enrolled-over-75-patients?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/briacell-announces-ongoing-phase-3-study-enrolled-over-75-patients?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2529702493","title":"BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529702493","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529702493?lang=en_us&edition=fundamental","pubTime":"2025-04-22 19:30","pubTimestamp":1745321400,"startTime":"0","endTime":"0","summary":"Over 75 patients enrolled in BriaCell’s pivotal Phase 3 study of Bria-IMT plus immune check point inhibitor in metastatic breast cancer . BriaCell’s pivotal Phase 3 clinical study is evaluating BriaCell’s lead clinical candidate, Bria-IMT, plus immune check point inhibitor versus physician’s choice in advanced metastatic breast cancer .About BriaCell’s Pivotal Phase 3 Clinical Study of Bria-IMT Combination Regimen in MBC patients. Interim data will be analyzed once 144 patient events  occur, comparing the overall survival  in patients treated with the Bria-IMT combination regimen versus those treated with physician’s choice as the primary endpoint. Positive results of the pivotal Phase 3 study could result in full approval and marketing authorization for Bria-IMT in MBC patients. BriaCell recently announced positive Phase 2 survival data in a similar MBC patient population treated with the same Bria-IMT combination regimen. The Bria-IMT combination regimen has received FDA Fast Track d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-enrollment-pace-accelerating-phase-113000724.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCTXW","AEIS","BCTX"],"gpt_icon":0},{"id":"2528220792","title":"BriaCell Therapeutics Stock Rises on Data for Late Stage Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2528220792","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528220792?lang=en_us&edition=fundamental","pubTime":"2025-04-17 01:32","pubTimestamp":1744824720,"startTime":"0","endTime":"0","summary":"Shares of BriaCell Therapeutics climbed after the company said its late stage breast cancer treatment outperformed leading antibody-drug conjugates for some patients in its Phase 2 study.The stock rose 16% to $4.34 on Wednesday. Shares have declined 87% over the past 12 months.The biotechnology company said its Bria-IMT plus check point inhibitors showed a 17.3-month survival rate for patients with hormone receptor-positive breast cancer, exceeding the 14.4 months of Trodelvy, the current ADC standard of care.For patients with triple negative breast cancer, the survival data for the treatment was similar to that of Trodelvy but higher than that of chemotherapy, the company said.Patients with hormone receptor-positive and triple negative breast cancer represent a significant proportion of the patient population, yet are the most difficult groups to treat, Chief Medical Officer Dr. Giuseppe Del Priore said.The Phase 2 data shows Bria-IMT has the potential to provide an effective and well","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCTX","BK4007","BK4139","LENZ","SSI"],"gpt_icon":0},{"id":"2527215015","title":"BriaCell Says Breast Cancer Therapy Shows Positive Survival Data; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2527215015","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527215015?lang=en_us&edition=fundamental","pubTime":"2025-04-16 20:14","pubTimestamp":1744805683,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics  said Wednesday that a phase 2 study of its Bria-IMT regimen with check point inhibitors to treat metastatic breast cancer showed positive survival results.The study showed a median survival of 17.3 months in certain patients, surpassing the 14.4 months seen for the antibody-drug conjugate treatment Trodelvy, the company said .For triple-negative breast cancer, the company said Bria-IMT showed survival comparable to Trodelvy but significantly better than chemotherapy, with a 70% improvement.The drug developer said it plans to further evaluate the results in an ongoing phase 3 trial focused on overall survival.BriaCell shares rose 27% in recent premarket trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BCTX"],"gpt_icon":0},{"id":"2527202290","title":"BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2527202290","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527202290?lang=en_us&edition=fundamental","pubTime":"2025-04-16 19:30","pubTimestamp":1744803000,"startTime":"0","endTime":"0","summary":"Median overall survival of 17.3 months in Bria-IMT treated patients with hormone receptor positive (HR+) metastatic breast cancer markedly exceeds historical data of 14.4 months in TRODELVY  in similar heavily pre-treated patients. Survival data in triple negative breast cancer patients treated with the BriaCell regimen was comparable to TRODELVY. PHILADELPHIA and VANCOUVER, British Columbia, April 16, 2025  -- BriaCell Therapeutics Corp.   , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, announces new positive survival data in its Phase 2 study of Bria-IMT plus check point inhibitors , outperforming ADC drugs in hormone receptor positive (HR+) metastatic breast cancer  patients.Table 1: Comparable Analysis of median overall survival  for the BriaCell Phase 2 study of BriaCell’s Bria-IMT plus CPI versus other drugs in MBC patient subsets","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/briacell-phase-2-survival-data-113000357.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BCTXW","BCTX","BK4086","SMP","HR","CPI","BK4203","BK4213","PR","BK4124","MBC","BK4225","BK4139"],"gpt_icon":0},{"id":"2526563169","title":"BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3","url":"https://stock-news.laohu8.com/highlight/detail?id=2526563169","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526563169?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:00","pubTimestamp":1744286400,"startTime":"0","endTime":"0","summary":"BriaPro is developing novel antibodies to B7-H3, a key cancer antigen and immune checkpointHighly expressed on the cell surfaces of both tumor and immune cells, B7-H3 is a promising anti-cancer target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/10/3059195/0/en/BriaCell-s-Subsidiary-BriaPro-Develops-Novel-Antibodies-to-Anti-Cancer-Target-B7-H3.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCT","BK4139","BCTX","BK4090"],"gpt_icon":0},{"id":"2522053418","title":"BriaCell to Showcase Cancer Immunotherapy Advances at AACR 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522053418","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522053418?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:48","pubTimestamp":1742993327,"startTime":"0","endTime":"0","summary":"BriaCell Therapeutics ( ($TSE:BCT) ) has provided an announcement. BriaCell Therapeutics announced it will present clinical and preclinical data th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/briacell-to-showcase-cancer-immunotherapy-advances-at-aacr-2025?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/briacell-to-showcase-cancer-immunotherapy-advances-at-aacr-2025?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCTX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":66,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BCTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-12","symbol":"BCTX","fiscalQuarterEnding":"2025/01","expectedEps":-1.94,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"post","actualEps":-2.33},{"market":"US","date":"2025-01-29","symbol":"BCTX","defaultRemindTime":1738161000000,"type":"split","dateTimestamp":1738126800000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"US","date":"2024-12-16","symbol":"BCTX","fiscalQuarterEnding":"2024/10","expectedEps":-0.08,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1734325200000,"reportTimeType":"post","actualEps":-0.22},{"market":"US","date":"2024-10-28","symbol":"BCTX","fiscalQuarterEnding":"2024/07","expectedEps":-0.52,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730088000000,"reportTimeType":"post","actualEps":-0.07},{"market":"US","date":"2024-06-14","symbol":"BCTX","fiscalQuarterEnding":"2024/04","expectedEps":-0.55,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1718337600000,"reportTimeType":"post","actualEps":0.11}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BCTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BCTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1727150400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BCTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BCTX","date":"2025-04-29","current":-1.596869,"percent":0.696994,"low":-302.251863,"twenty":-5.65468,"median":-3.113448,"eighty":-1.020956,"high":84.325675,"avg":-11.837497,"sd":56.45285,"marketCap":18510901.2},"quantilePoints":[{"date":"2020-05-01","current":-1.194918,"twenty":-6.901267,"median":-3.719807,"eighty":-2.203357,"marketCap":5685667.66},{"date":"2020-05-08","current":-0.967776,"twenty":-6.855079,"median":-3.671081,"eighty":-2.171931,"marketCap":4659290.31},{"date":"2020-05-15","current":-0.958088,"twenty":-6.855079,"median":-3.614611,"eighty":-2.158278,"marketCap":4560234.06},{"date":"2020-05-22","current":-1.033443,"twenty":-6.855079,"median":-3.614611,"eighty":-2.117207,"marketCap":4940081.11},{"date":"2020-05-29","current":-1.07435,"twenty":-6.855079,"median":-3.614611,"eighty":-2.045974,"marketCap":5219064.87},{"date":"2020-06-05","current":-1.022678,"twenty":-6.765172,"median":-3.614611,"eighty":-2.00486,"marketCap":5116020.2},{"date":"2020-06-12","current":-1.00653,"twenty":-6.742695,"median":-3.571015,"eighty":-2.00486,"marketCap":4959987.07},{"date":"2020-06-19","current":-1.032366,"twenty":-6.665071,"median":-3.571015,"eighty":-1.93222,"marketCap":5096214.43},{"date":"2020-06-26","current":-0.83429,"twenty":-6.645665,"median":-3.519989,"eighty":-1.892731,"marketCap":4082184.24},{"date":"2020-07-02","current":-0.740992,"twenty":-6.645665,"median":-3.514785,"eighty":-1.888591,"marketCap":3238307.01},{"date":"2020-07-10","current":-0.75314,"twenty":-6.645665,"median":-3.514785,"eighty":-1.888591,"marketCap":3292071.66},{"date":"2020-07-17","current":-0.850319,"twenty":-6.645665,"median":-3.477974,"eighty":-1.888591,"marketCap":3722687.19},{"date":"2020-07-24","current":-0.710624,"twenty":-6.645665,"median":-3.427679,"eighty":-1.837788,"marketCap":3147315.43},{"date":"2020-07-31","current":-1.160078,"twenty":-6.645665,"median":-3.424951,"eighty":-1.814762,"marketCap":5147938.51},{"date":"2020-08-07","current":-1.068973,"twenty":-6.645665,"median":-3.400087,"eighty":-1.735798,"marketCap":4750353.29},{"date":"2020-08-14","current":-0.94168,"twenty":-6.645665,"median":-3.375852,"eighty":-1.735798,"marketCap":4222699.73},{"date":"2020-08-21","current":-1.120228,"twenty":-6.645665,"median":-3.28601,"eighty":-1.735798,"marketCap":5046151.28},{"date":"2020-08-28","current":-1.037248,"twenty":-6.645665,"median":-3.280373,"eighty":-1.735798,"marketCap":4703699.04},{"date":"2020-09-04","current":-0.898948,"twenty":-6.645665,"median":-3.278649,"eighty":-1.731209,"marketCap":4071754.75},{"date":"2020-09-11","current":-0.777245,"twenty":-6.645665,"median":-3.278649,"eighty":-1.731209,"marketCap":3504450.14},{"date":"2020-09-18","current":-0.829798,"twenty":-6.645665,"median":-3.278649,"eighty":-1.694915,"marketCap":3744445.71},{"date":"2020-09-25","current":-0.797989,"twenty":-6.627874,"median":-3.278649,"eighty":-1.562218,"marketCap":3536598.46},{"date":"2020-10-02","current":-0.753733,"twenty":-6.601187,"median":-3.278649,"eighty":-1.562218,"marketCap":3366695.98},{"date":"2020-10-09","current":-0.746818,"twenty":-6.601187,"median":-3.278649,"eighty":-1.562218,"marketCap":3379751.62},{"date":"2020-10-16","current":-0.663839,"twenty":-6.601187,"median":-3.278649,"eighty":-1.4998,"marketCap":2992511.55},{"date":"2020-10-23","current":-0.624756,"twenty":-6.601187,"median":-3.236214,"eighty":-1.407897,"marketCap":2824644.94},{"date":"2020-10-30","current":-0.703987,"twenty":-6.601187,"median":-3.235281,"eighty":-1.388638,"marketCap":3144329.88},{"date":"2020-11-06","current":-0.714378,"twenty":-6.601187,"median":-3.218211,"eighty":-1.388638,"marketCap":3258498.53},{"date":"2020-11-13","current":-0.67801,"twenty":-6.578464,"median":-3.181932,"eighty":-1.388638,"marketCap":3061711.52},{"date":"2020-11-20","current":-0.662423,"twenty":-6.54438,"median":-3.12962,"eighty":-1.388638,"marketCap":3013376.09},{"date":"2020-11-27","current":-0.636446,"twenty":-6.513516,"median":-3.12962,"eighty":-1.388638,"marketCap":2914006.07},{"date":"2020-12-04","current":-0.707065,"twenty":-6.390062,"median":-3.12962,"eighty":-1.356079,"marketCap":2845608.97},{"date":"2020-12-11","current":-0.773946,"twenty":-6.381509,"median":-3.12962,"eighty":-1.352822,"marketCap":3114773.93},{"date":"2020-12-18","current":-0.735345,"twenty":-6.347049,"median":-3.12962,"eighty":-1.336575,"marketCap":2959420.57},{"date":"2020-12-24","current":-0.836035,"twenty":-6.346066,"median":-3.094616,"eighty":-1.291804,"marketCap":3364651.9},{"date":"2020-12-31","current":-1.129288,"twenty":-6.346066,"median":-3.094616,"eighty":-1.255203,"marketCap":3622925.76},{"date":"2021-01-08","current":-1.324945,"twenty":-6.187414,"median":-3.048831,"eighty":-1.25389,"marketCap":4250624.57},{"date":"2021-01-15","current":-1.322583,"twenty":-6.147751,"median":-3.048831,"eighty":-1.25389,"marketCap":4243048.17},{"date":"2021-01-22","current":-1.285795,"twenty":-6.147751,"median":-3.048831,"eighty":-1.252577,"marketCap":4125024.36},{"date":"2021-01-29","current":-1.033493,"twenty":-6.144098,"median":-3.048831,"eighty":-1.233468,"marketCap":3315603.73},{"date":"2021-02-05","current":-0.979361,"twenty":-6.141662,"median":-3.022346,"eighty":-1.215058,"marketCap":3141937.35},{"date":"2021-02-12","current":-1.136597,"twenty":-6.141662,"median":-2.99586,"eighty":-1.200301,"marketCap":3646375.49},{"date":"2021-02-19","current":-1.5257,"twenty":-6.092851,"median":-2.99586,"eighty":-1.206204,"marketCap":4894675.19},{"date":"2021-02-26","current":-5.880448,"twenty":-6.141662,"median":-2.99586,"eighty":-1.215058,"marketCap":18865366.17},{"date":"2021-03-05","current":-5.636106,"twenty":-6.141662,"median":-2.99586,"eighty":-1.215058,"marketCap":18081479},{"date":"2021-03-12","current":-6.388252,"twenty":-6.145315,"median":-3.048831,"eighty":-1.215058,"marketCap":20494476.48},{"date":"2021-03-19","current":-6.881296,"twenty":-6.274962,"median":-3.048831,"eighty":-1.21635,"marketCap":22076237.3},{"date":"2021-03-26","current":-5.939184,"twenty":-6.346066,"median":-3.048831,"eighty":-1.223649,"marketCap":19053799.3},{"date":"2021-04-01","current":-11.625817,"twenty":-6.346311,"median":-3.048831,"eighty":-1.231688,"marketCap":22159375.57},{"date":"2021-04-09","current":-15.545819,"twenty":-6.390062,"median":-3.094616,"eighty":-1.232281,"marketCap":29631093.38},{"date":"2021-04-16","current":-11.439094,"twenty":-6.596553,"median":-3.094616,"eighty":-1.237049,"marketCap":21803475.06},{"date":"2021-04-23","current":-13.006004,"twenty":-6.601187,"median":-3.12962,"eighty":-1.247028,"marketCap":24790080.19},{"date":"2021-04-30","current":-14.475691,"twenty":-6.645665,"median":-3.12962,"eighty":-1.249331,"marketCap":27591376.06},{"date":"2021-05-07","current":-13.024617,"twenty":-6.645665,"median":-3.12962,"eighty":-1.252721,"marketCap":24825557.92},{"date":"2021-05-14","current":-12.57752,"twenty":-6.645665,"median":-3.12962,"eighty":-1.255203,"marketCap":23973368.86},{"date":"2021-05-21","current":-12.304406,"twenty":-6.645665,"median":-3.12962,"eighty":-1.256303,"marketCap":23452800.64},{"date":"2021-05-28","current":-12.952609,"twenty":-6.742695,"median":-3.181932,"eighty":-1.26154,"marketCap":24688307.36},{"date":"2021-06-04","current":-20.072293,"twenty":-6.855079,"median":-3.218211,"eighty":-1.264891,"marketCap":38258774.07},{"date":"2021-06-11","current":-22.633757,"twenty":-6.888208,"median":-3.235281,"eighty":-1.28256,"marketCap":43141049.43},{"date":"2021-06-18","current":-41.108292,"twenty":-6.901267,"median":-3.236214,"eighty":-1.285795,"marketCap":78354418.87},{"date":"2021-06-25","current":-41.108237,"twenty":-6.901267,"median":-3.278649,"eighty":-1.288742,"marketCap":78354314.19},{"date":"2021-07-02","current":43.861646,"twenty":-6.901267,"median":-3.244236,"eighty":-1.264891,"marketCap":75295664.85},{"date":"2021-07-09","current":48.206127,"twenty":-6.901267,"median":-3.235747,"eighty":-1.254583,"marketCap":82753673.6},{"date":"2021-07-16","current":42.887011,"twenty":-6.901267,"median":-3.235103,"eighty":-1.234062,"marketCap":73622545.95},{"date":"2021-07-23","current":39.450972,"twenty":-6.901267,"median":-3.218211,"eighty":-1.215058,"marketCap":67724024.93},{"date":"2021-07-30","current":45.792388,"twenty":-6.901267,"median":-3.145653,"eighty":-1.200301,"marketCap":78610097.43},{"date":"2021-08-06","current":50.814373,"twenty":-6.901267,"median":-3.12962,"eighty":-1.182982,"marketCap":87231155.12},{"date":"2021-08-13","current":53.427867,"twenty":-6.901267,"median":-3.12962,"eighty":-1.162623,"marketCap":91717642.17},{"date":"2021-08-20","current":46.64092,"twenty":-6.901267,"median":-3.12962,"eighty":-1.158863,"marketCap":80066741.61},{"date":"2021-08-27","current":56.608911,"twenty":-6.89082,"median":-3.12962,"eighty":-1.129989,"marketCap":97178424.31},{"date":"2021-09-03","current":60.910491,"twenty":-6.882678,"median":-3.094616,"eighty":-1.127549,"marketCap":104562785.46},{"date":"2021-09-10","current":67.071728,"twenty":-6.865566,"median":-3.094616,"eighty":-1.120228,"marketCap":115139553.74},{"date":"2021-09-17","current":68.933411,"twenty":-6.855079,"median":-3.048831,"eighty":-1.119612,"marketCap":118335435.49},{"date":"2021-09-24","current":81.278873,"twenty":-6.855079,"median":-3.048831,"eighty":-1.08471,"marketCap":139528434.7},{"date":"2021-10-01","current":72.633662,"twenty":-6.855079,"median":-3.048831,"eighty":-1.076073,"marketCap":124687519.43},{"date":"2021-10-08","current":64.918457,"twenty":-6.818498,"median":-3.048831,"eighty":-1.072199,"marketCap":111443112.38},{"date":"2021-10-15","current":73.756862,"twenty":-6.763261,"median":-2.99586,"eighty":-1.062306,"marketCap":126615676.69},{"date":"2021-10-22","current":66.162889,"twenty":-6.742695,"median":-2.99586,"eighty":-1.052084,"marketCap":113579384.1},{"date":"2021-10-29","current":-8.954923,"twenty":-6.763261,"median":-2.99586,"eighty":-1.050483,"marketCap":123723005.39},{"date":"2021-11-05","current":-11.174088,"twenty":-6.855079,"median":-2.99586,"eighty":-1.051682,"marketCap":154383427.08},{"date":"2021-11-12","current":-11.103847,"twenty":-6.901267,"median":-3.048831,"eighty":-1.052084,"marketCap":153412972.99},{"date":"2021-11-19","current":-11.711278,"twenty":-6.901267,"median":-3.048831,"eighty":-1.052084,"marketCap":161805356.93},{"date":"2021-11-26","current":-11.352848,"twenty":-6.901267,"median":-3.048831,"eighty":-1.05214,"marketCap":156853223.33},{"date":"2021-12-03","current":-10.319329,"twenty":-6.906244,"median":-3.048831,"eighty":-1.054844,"marketCap":142573911.38},{"date":"2021-12-10","current":-8.95298,"twenty":-7.108971,"median":-3.094616,"eighty":-1.061129,"marketCap":123696160.41},{"date":"2021-12-17","current":-3.356446,"twenty":-7.108971,"median":-3.094616,"eighty":-1.065615,"marketCap":137373833.34},{"date":"2021-12-23","current":-3.605298,"twenty":-7.106081,"median":-3.094616,"eighty":-1.067431,"marketCap":147558912.96},{"date":"2021-12-31","current":-3.2055,"twenty":-7.07168,"median":-3.12962,"eighty":-1.068973,"marketCap":131195852.2},{"date":"2022-01-07","current":-3.304578,"twenty":-6.966172,"median":-3.12962,"eighty":-1.070048,"marketCap":135250957.52},{"date":"2022-01-14","current":-3.276233,"twenty":-6.907903,"median":-3.12962,"eighty":-1.074565,"marketCap":134090840.47},{"date":"2022-01-21","current":-2.798974,"twenty":-6.901267,"median":-3.12962,"eighty":-1.075427,"marketCap":114557380.95},{"date":"2022-01-28","current":-2.311425,"twenty":-6.901267,"median":-3.12962,"eighty":-1.075427,"marketCap":94602853.38},{"date":"2022-02-04","current":-2.585016,"twenty":-6.901267,"median":-3.12962,"eighty":-1.075427,"marketCap":105800472.34},{"date":"2022-02-11","current":-2.574394,"twenty":-6.901267,"median":-3.095384,"eighty":-1.076288,"marketCap":105365702.64},{"date":"2022-02-18","current":-2.725831,"twenty":-6.901267,"median":-3.071724,"eighty":-1.076288,"marketCap":111563783.36},{"date":"2022-02-25","current":-2.605744,"twenty":-6.901267,"median":-3.048831,"eighty":-1.076288,"marketCap":106648840.35},{"date":"2022-03-04","current":-2.45,"twenty":-6.901267,"median":-3.048831,"eighty":-1.076288,"marketCap":100274445.64},{"date":"2022-03-11","current":-3.150199,"twenty":-6.901267,"median":-2.99586,"eighty":-1.076288,"marketCap":128932446.5},{"date":"2022-03-18","current":-4.63064,"twenty":-6.901267,"median":-2.99586,"eighty":-1.076288,"marketCap":136751667.66},{"date":"2022-03-25","current":-4.959024,"twenty":-6.901267,"median":-2.99586,"eighty":-1.076288,"marketCap":146449468.35},{"date":"2022-04-01","current":-5.372027,"twenty":-6.901267,"median":-2.99586,"eighty":-1.076288,"marketCap":158646237.38},{"date":"2022-04-08","current":-6.185042,"twenty":-6.901267,"median":-2.99586,"eighty":-1.076288,"marketCap":182656125.79},{"date":"2022-04-14","current":-4.453613,"twenty":-6.860322,"median":-2.99586,"eighty":-1.076288,"marketCap":131523705.24},{"date":"2022-04-22","current":-3.878021,"twenty":-6.752978,"median":-2.99586,"eighty":-1.076288,"marketCap":114525397.21},{"date":"2022-04-29","current":-3.641316,"twenty":-6.645665,"median":-2.99586,"eighty":-1.076288,"marketCap":107535048.61},{"date":"2022-05-06","current":-3.072162,"twenty":-6.645665,"median":-2.99586,"eighty":-1.076288,"marketCap":90726823.92},{"date":"2022-05-13","current":-2.54054,"twenty":-6.645665,"median":-2.957261,"eighty":-1.076288,"marketCap":75026989.28},{"date":"2022-05-20","current":-2.603331,"twenty":-6.601187,"median":-2.944384,"eighty":-1.076288,"marketCap":76881350.63},{"date":"2022-05-27","current":-2.500508,"twenty":-6.582653,"median":-2.879452,"eighty":-1.076288,"marketCap":73844779.02},{"date":"2022-06-03","current":-2.796081,"twenty":-6.390062,"median":-2.879452,"eighty":-1.076288,"marketCap":82573614.36},{"date":"2022-06-10","current":-3.228053,"twenty":-6.346066,"median":-2.879452,"eighty":-1.076288,"marketCap":95330570.94},{"date":"2022-06-17","current":-2.360174,"twenty":-6.147751,"median":-2.879452,"eighty":-1.076288,"marketCap":88084104.21},{"date":"2022-06-24","current":-2.565544,"twenty":-5.980067,"median":-2.879452,"eighty":-1.076073,"marketCap":95748705.58},{"date":"2022-07-01","current":-2.369552,"twenty":-5.929434,"median":-2.824972,"eighty":-1.076073,"marketCap":88434078.2},{"date":"2022-07-08","current":-2.522795,"twenty":-5.873312,"median":-2.813287,"eighty":-1.076073,"marketCap":94153269.03},{"date":"2022-07-15","current":-2.536466,"twenty":-5.686823,"median":-2.782754,"eighty":-1.076073,"marketCap":94663497.72},{"date":"2022-07-22","current":-2.67748,"twenty":-5.560175,"median":-2.711973,"eighty":-1.076073,"marketCap":99926265.32},{"date":"2022-07-29","current":-2.718655,"twenty":-5.361507,"median":-2.710072,"eighty":-1.076073,"marketCap":101462938.69},{"date":"2022-08-05","current":-2.742975,"twenty":-5.321613,"median":-2.710072,"eighty":-1.076073,"marketCap":102370609.86},{"date":"2022-08-12","current":-2.690705,"twenty":-5.261435,"median":-2.710072,"eighty":-1.076073,"marketCap":100419836.34},{"date":"2022-08-19","current":-2.936108,"twenty":-5.156179,"median":-2.710072,"eighty":-1.076073,"marketCap":109578552.03},{"date":"2022-08-26","current":-2.923855,"twenty":-5.156179,"median":-2.710072,"eighty":-1.076073,"marketCap":109121230.35},{"date":"2022-09-02","current":-3.380914,"twenty":-5.130331,"median":-2.710072,"eighty":-1.076073,"marketCap":126179122.45},{"date":"2022-09-09","current":-3.391073,"twenty":-5.024685,"median":-2.710072,"eighty":-1.076073,"marketCap":126558266.33},{"date":"2022-09-16","current":-3.414037,"twenty":-4.957864,"median":-2.710072,"eighty":-1.076073,"marketCap":127415327.83},{"date":"2022-09-23","current":-2.424525,"twenty":-4.957864,"median":-2.710072,"eighty":-1.076073,"marketCap":90485737.24},{"date":"2022-09-30","current":-2.377375,"twenty":-4.953423,"median":-2.696274,"eighty":-1.076073,"marketCap":88726057.76},{"date":"2022-10-07","current":-2.518738,"twenty":-4.902915,"median":-2.690705,"eighty":-1.076073,"marketCap":94001862.58},{"date":"2022-10-14","current":-2.733879,"twenty":-4.808856,"median":-2.67793,"eighty":-1.076073,"marketCap":102031133.25},{"date":"2022-10-21","current":-2.551468,"twenty":-4.776515,"median":-2.673146,"eighty":-1.076073,"marketCap":95223378.47},{"date":"2022-10-28","current":-3.081174,"twenty":-4.776515,"median":-2.672623,"eighty":-1.076073,"marketCap":82695330.16},{"date":"2022-11-04","current":-3.304818,"twenty":-4.759549,"median":-2.672623,"eighty":-1.076073,"marketCap":88697680.39},{"date":"2022-11-11","current":-3.305739,"twenty":-4.63075,"median":-2.672623,"eighty":-1.076073,"marketCap":88722418.15},{"date":"2022-11-18","current":-3.266263,"twenty":-4.630684,"median":-2.672623,"eighty":-1.076073,"marketCap":87662911.81},{"date":"2022-11-25","current":-3.315659,"twenty":-4.600414,"median":-2.672623,"eighty":-1.076073,"marketCap":88988641.58},{"date":"2022-12-02","current":-3.189802,"twenty":-4.538035,"median":-2.672623,"eighty":-1.076073,"marketCap":85610770.13},{"date":"2022-12-09","current":-3.303865,"twenty":-4.452644,"median":-2.672623,"eighty":-1.076073,"marketCap":88672110.45},{"date":"2022-12-16","current":-216.225143,"twenty":-4.452644,"median":-2.672623,"eighty":-1.076073,"marketCap":89075893.52},{"date":"2022-12-23","current":-174.115527,"twenty":-4.452644,"median":-2.672623,"eighty":-1.076073,"marketCap":71728458.61},{"date":"2022-12-30","current":-164.210785,"twenty":-4.452644,"median":-2.672623,"eighty":-1.076073,"marketCap":67648110.71},{"date":"2023-01-06","current":-200.250136,"twenty":-4.452644,"median":-2.672623,"eighty":-1.076073,"marketCap":82494845.79},{"date":"2023-01-13","current":-249.691308,"twenty":-4.453032,"median":-2.672623,"eighty":-1.076073,"marketCap":102862581.65},{"date":"2023-01-20","current":-263.8055,"twenty":-4.576584,"median":-2.672623,"eighty":-1.076073,"marketCap":108677050.27},{"date":"2023-01-27","current":-284.932717,"twenty":-4.63075,"median":-2.672623,"eighty":-1.076073,"marketCap":117380596.87},{"date":"2023-02-03","current":-268.256889,"twenty":-4.639843,"median":-2.672623,"eighty":-1.076073,"marketCap":110510839.85},{"date":"2023-02-10","current":-252.614224,"twenty":-4.759549,"median":-2.672623,"eighty":-1.076073,"marketCap":104066703.34},{"date":"2023-02-17","current":-276.203385,"twenty":-4.776515,"median":-2.672623,"eighty":-1.076073,"marketCap":113784470.1},{"date":"2023-02-24","current":-265.54624,"twenty":-4.776515,"median":-2.672623,"eighty":-1.076073,"marketCap":109394163.61},{"date":"2023-03-03","current":-281.542109,"twenty":-4.808856,"median":-2.672623,"eighty":-1.076073,"marketCap":115983805.79},{"date":"2023-03-10","current":-232.412313,"twenty":-4.902915,"median":-2.672623,"eighty":-1.076073,"marketCap":95744344.03},{"date":"2023-03-17","current":-4.558412,"twenty":-4.953423,"median":-2.672623,"eighty":-1.076073,"marketCap":106914032.06},{"date":"2023-03-24","current":-4.599631,"twenty":-4.953423,"median":-2.672623,"eighty":-1.076073,"marketCap":107880778.1},{"date":"2023-03-31","current":-4.904729,"twenty":-4.87634,"median":-2.672623,"eighty":-1.076288,"marketCap":115036636.83},{"date":"2023-04-06","current":-4.710646,"twenty":-4.808856,"median":-2.672623,"eighty":-1.076288,"marketCap":110484567.92},{"date":"2023-04-14","current":-4.725574,"twenty":-4.808856,"median":-2.672623,"eighty":-1.076073,"marketCap":110834686.68},{"date":"2023-04-21","current":-4.7472,"twenty":-4.808856,"median":-2.672623,"eighty":-1.076073,"marketCap":111341899.52},{"date":"2023-04-28","current":-4.685027,"twenty":-4.808856,"median":-2.672623,"eighty":-1.076073,"marketCap":109883683.46},{"date":"2023-05-05","current":-4.642487,"twenty":-4.808856,"median":-2.672623,"eighty":-1.076073,"marketCap":108885943.69},{"date":"2023-05-12","current":-4.611755,"twenty":-4.808856,"median":-2.672623,"eighty":-1.076073,"marketCap":108165158.17},{"date":"2023-05-19","current":-3.88116,"twenty":-4.808856,"median":-2.672623,"eighty":-1.076073,"marketCap":91029598.41},{"date":"2023-05-26","current":-4.108178,"twenty":-4.808856,"median":-2.672623,"eighty":-1.076073,"marketCap":96354149.98},{"date":"2023-06-02","current":-4.250136,"twenty":-4.808856,"median":-2.672623,"eighty":-1.076073,"marketCap":99683654.86},{"date":"2023-06-09","current":-4.265658,"twenty":-4.776515,"median":-2.672623,"eighty":-1.076073,"marketCap":100047716.43},{"date":"2023-06-16","current":-4.057902,"twenty":-4.776515,"median":-2.672623,"eighty":-1.076073,"marketCap":95402125.62},{"date":"2023-06-23","current":-5.229121,"twenty":-4.770008,"median":-2.672623,"eighty":-1.075857,"marketCap":95871181.46},{"date":"2023-06-30","current":-5.461992,"twenty":-4.757638,"median":-2.672623,"eighty":-1.075642,"marketCap":100140662.98},{"date":"2023-07-07","current":-5.322011,"twenty":-4.7472,"median":-2.672623,"eighty":-1.075427,"marketCap":97574228.79},{"date":"2023-07-14","current":-5.64612,"twenty":-4.760248,"median":-2.672623,"eighty":-1.075427,"marketCap":103516475.65},{"date":"2023-07-21","current":-5.607113,"twenty":-4.760248,"median":-2.672623,"eighty":-1.075427,"marketCap":102801319.86},{"date":"2023-07-28","current":-5.251888,"twenty":-4.760248,"median":-2.672623,"eighty":-1.075427,"marketCap":96288590.55},{"date":"2023-08-04","current":-5.880115,"twenty":-4.760248,"median":-2.672623,"eighty":-1.075427,"marketCap":107806576.23},{"date":"2023-08-11","current":-6.081982,"twenty":-4.760248,"median":-2.672623,"eighty":-1.075427,"marketCap":111507624.92},{"date":"2023-08-18","current":-6.284817,"twenty":-4.808856,"median":-2.672623,"eighty":-1.075427,"marketCap":115226411.1},{"date":"2023-08-25","current":-6.426056,"twenty":-4.839935,"median":-2.672623,"eighty":-1.075427,"marketCap":117815893.84},{"date":"2023-09-01","current":-6.246167,"twenty":-4.876191,"median":-2.672623,"eighty":-1.075427,"marketCap":114517797.15},{"date":"2023-09-08","current":-5.863816,"twenty":-4.986961,"median":-2.672623,"eighty":-1.075427,"marketCap":107507735.22},{"date":"2023-09-15","current":-5.470913,"twenty":-5.112985,"median":-2.672623,"eighty":-1.075427,"marketCap":100304214.22},{"date":"2023-09-22","current":-5.041499,"twenty":-5.131969,"median":-2.672623,"eighty":-1.075427,"marketCap":92431292.03},{"date":"2023-09-29","current":-5.103522,"twenty":-5.112985,"median":-2.672623,"eighty":-1.075427,"marketCap":93568437.16},{"date":"2023-10-06","current":-5.114364,"twenty":-5.131969,"median":-2.672623,"eighty":-1.075427,"marketCap":93767214.56},{"date":"2023-10-13","current":-4.516353,"twenty":-5.143081,"median":-2.672623,"eighty":-1.075427,"marketCap":82803234.54},{"date":"2023-10-20","current":-4.797106,"twenty":-5.143081,"median":-2.672623,"eighty":-1.075427,"marketCap":87950574.01},{"date":"2023-10-27","current":-3.426822,"twenty":-5.161178,"median":-2.672623,"eighty":-1.075427,"marketCap":69572693.02},{"date":"2023-11-03","current":-3.105061,"twenty":-5.161178,"median":-2.672623,"eighty":-1.075427,"marketCap":63040169.53},{"date":"2023-11-10","current":-3.111355,"twenty":-5.161178,"median":-2.672623,"eighty":-1.075427,"marketCap":63167959.23},{"date":"2023-11-17","current":-3.252781,"twenty":-5.161178,"median":-2.672623,"eighty":-1.075427,"marketCap":66039229.82},{"date":"2023-11-24","current":-3.620216,"twenty":-5.161178,"median":-2.672623,"eighty":-1.075427,"marketCap":73499045.9},{"date":"2023-12-01","current":-4.1294,"twenty":-5.161178,"median":-2.672623,"eighty":-1.075427,"marketCap":83836709.45},{"date":"2023-12-08","current":-3.82727,"twenty":-5.155145,"median":-2.672623,"eighty":-1.075427,"marketCap":77702741.39},{"date":"2023-12-15","current":-5.13915,"twenty":-5.155145,"median":-2.672623,"eighty":-1.075427,"marketCap":67807544.61},{"date":"2023-12-22","current":-4.909414,"twenty":-5.155145,"median":-2.672623,"eighty":-1.075427,"marketCap":64776327.05},{"date":"2023-12-29","current":-6.653907,"twenty":-5.228315,"median":-2.677299,"eighty":-1.075427,"marketCap":87793716.33},{"date":"2024-01-05","current":-6.439875,"twenty":-5.265263,"median":-2.678987,"eighty":-1.075427,"marketCap":84969712.9},{"date":"2024-01-12","current":-5.146202,"twenty":-5.357942,"median":-2.697932,"eighty":-1.075427,"marketCap":67900573.68},{"date":"2024-01-19","current":-5.302151,"twenty":-5.366925,"median":-2.710072,"eighty":-1.075427,"marketCap":69958225.94},{"date":"2024-01-26","current":-4.773258,"twenty":-5.36653,"median":-2.710072,"eighty":-1.075427,"marketCap":62979838.52},{"date":"2024-02-02","current":-4.725586,"twenty":-5.36653,"median":-2.711022,"eighty":-1.075427,"marketCap":62350845.55},{"date":"2024-02-09","current":-4.684765,"twenty":-5.36653,"median":-2.722243,"eighty":-1.075427,"marketCap":61812237.02},{"date":"2024-02-16","current":-3.900489,"twenty":-5.36653,"median":-2.739213,"eighty":-1.075427,"marketCap":51464269.16},{"date":"2024-02-23","current":-4.289008,"twenty":-5.36653,"median":-2.769197,"eighty":-1.075427,"marketCap":56590501.66},{"date":"2024-03-01","current":-4.14992,"twenty":-5.366135,"median":-2.774122,"eighty":-1.075427,"marketCap":54755327.07},{"date":"2024-03-08","current":-3.50821,"twenty":-5.366135,"median":-2.774122,"eighty":-1.075427,"marketCap":46288408.72},{"date":"2024-03-15","current":-3.620326,"twenty":-5.366135,"median":-2.774122,"eighty":-1.075427,"marketCap":47767704.4},{"date":"2024-03-22","current":-2.829143,"twenty":-5.366135,"median":-2.774122,"eighty":-1.075427,"marketCap":35667431.77},{"date":"2024-03-28","current":-3.400291,"twenty":-5.366135,"median":-2.774122,"eighty":-1.075427,"marketCap":42867979.25},{"date":"2024-04-05","current":-3.58821,"twenty":-5.36653,"median":-2.773326,"eighty":-1.075427,"marketCap":45237109.13},{"date":"2024-04-12","current":-3.427213,"twenty":-5.36653,"median":-2.773326,"eighty":-1.075427,"marketCap":43207388.49},{"date":"2024-04-19","current":-2.71989,"twenty":-5.36653,"median":-2.758986,"eighty":-1.075427,"marketCap":34290061.24},{"date":"2024-04-26","current":-2.785339,"twenty":-5.366135,"median":-2.752109,"eighty":-1.075427,"marketCap":35115185.56},{"date":"2024-05-03","current":-2.821447,"twenty":-5.366135,"median":-2.752109,"eighty":-1.075427,"marketCap":35570407.78},{"date":"2024-05-10","current":-2.86246,"twenty":-5.366135,"median":-2.774122,"eighty":-1.075427,"marketCap":36087466.75},{"date":"2024-05-17","current":-1.824858,"twenty":-5.366135,"median":-2.765864,"eighty":-1.075427,"marketCap":23006266.39},{"date":"2024-05-24","current":-2.096097,"twenty":-5.366135,"median":-2.733879,"eighty":-1.075427,"marketCap":26425812.95},{"date":"2024-05-31","current":-2.271614,"twenty":-5.366135,"median":-2.725831,"eighty":-1.075427,"marketCap":28638576.9},{"date":"2024-06-07","current":-2.023883,"twenty":-5.366135,"median":-2.716472,"eighty":-1.075427,"marketCap":25515406.25},{"date":"2024-06-14","current":-1.940579,"twenty":-5.36653,"median":-2.711022,"eighty":-1.075427,"marketCap":24465175.94},{"date":"2024-06-21","current":-3.917461,"twenty":-5.366925,"median":-2.711973,"eighty":-1.075427,"marketCap":23488925.95},{"date":"2024-06-28","current":-3.139475,"twenty":-5.369986,"median":-2.711973,"eighty":-1.075427,"marketCap":18824153.21},{"date":"2024-07-05","current":-3.136537,"twenty":-5.369986,"median":-2.720404,"eighty":-1.075427,"marketCap":18806542.26},{"date":"2024-07-12","current":-2.798055,"twenty":-5.369986,"median":-2.728218,"eighty":-1.075427,"marketCap":16777011.44},{"date":"2024-07-15","current":-2.67821,"twenty":-5.369986,"median":-2.728218,"eighty":-1.075427,"marketCap":16058427.5},{"date":"2024-08-02","current":-2.158423,"twenty":-5.400183,"median":-2.765864,"eighty":-1.068973,"marketCap":12941806.9},{"date":"2024-08-09","current":-1.841364,"twenty":-5.400183,"median":-2.765864,"eighty":-1.068973,"marketCap":11040738.56},{"date":"2024-08-16","current":-1.735945,"twenty":-5.400183,"median":-2.765864,"eighty":-1.068973,"marketCap":10408649.04},{"date":"2024-08-23","current":-2.487631,"twenty":-5.400183,"median":-2.765864,"eighty":-1.068973,"marketCap":14915722.67},{"date":"2024-08-30","current":-2.307604,"twenty":-5.400183,"median":-2.765864,"eighty":-1.068973,"marketCap":13836292.69},{"date":"2024-09-06","current":-2.14212,"twenty":-5.400183,"median":-2.765864,"eighty":-1.068973,"marketCap":12844053.95},{"date":"2024-09-13","current":-1.88429,"twenty":-5.400183,"median":-2.765864,"eighty":-1.068973,"marketCap":11298119.08},{"date":"2024-09-20","current":-3.171185,"twenty":-5.400183,"median":-2.774122,"eighty":-1.068973,"marketCap":19014288.66},{"date":"2024-09-27","current":-3.726,"twenty":-5.400183,"median":-2.791072,"eighty":-1.068973,"marketCap":22340930.15},{"date":"2024-10-04","current":-5.693442,"twenty":-5.423023,"median":-2.813264,"eighty":-1.068973,"marketCap":34137630.14},{"date":"2024-10-11","current":-5.952031,"twenty":-5.46211,"median":-2.824972,"eighty":-1.068973,"marketCap":35688114.21},{"date":"2024-10-18","current":-5.030607,"twenty":-5.472175,"median":-2.829143,"eighty":-1.068973,"marketCap":30163299.57},{"date":"2024-10-25","current":-5.352458,"twenty":-5.478167,"median":-2.859172,"eighty":-1.068973,"marketCap":32093102.48},{"date":"2024-10-31","current":-5.474828,"twenty":-5.496237,"median":-2.891972,"eighty":-1.068973,"marketCap":26232453.53},{"date":"2024-11-08","current":-5.229459,"twenty":-5.565104,"median":-2.911728,"eighty":-1.068973,"marketCap":25056773.61},{"date":"2024-11-15","current":-4.483394,"twenty":-5.565104,"median":-2.943696,"eighty":-1.068973,"marketCap":21482028.17},{"date":"2024-11-22","current":-5.84133,"twenty":-5.572932,"median":-2.991224,"eighty":-1.068973,"marketCap":27988532.64},{"date":"2024-11-29","current":-6.406265,"twenty":-5.586093,"median":-3.043613,"eighty":-1.068973,"marketCap":30695402.02},{"date":"2024-12-06","current":-7.570373,"twenty":-5.623023,"median":-3.076668,"eighty":-1.068973,"marketCap":36273183.32},{"date":"2024-12-13","current":-5.008813,"twenty":-5.652695,"median":-3.104432,"eighty":-1.068973,"marketCap":23999557.32},{"date":"2024-12-20","current":-1.577258,"twenty":-5.652695,"median":-3.111716,"eighty":-1.068973,"marketCap":26174893.42},{"date":"2024-12-27","current":-1.405018,"twenty":-5.652695,"median":-3.111716,"eighty":-1.068973,"marketCap":23316534.22},{"date":"2025-01-03","current":-1.512854,"twenty":-5.652695,"median":-3.111716,"eighty":-1.068973,"marketCap":25106084.76},{"date":"2025-01-10","current":-1.128291,"twenty":-5.653687,"median":-3.112077,"eighty":-1.068973,"marketCap":18724203.35},{"date":"2025-01-17","current":-1.017694,"twenty":-5.653687,"median":-3.112077,"eighty":-1.054844,"marketCap":16888811.09},{"date":"2025-01-24","current":-1.037552,"twenty":-5.653687,"median":-3.112077,"eighty":-1.052084,"marketCap":17218367.22},{"date":"2025-01-31","current":-1.014255,"twenty":-5.653687,"median":-3.112077,"eighty":-1.050185,"marketCap":16831738.53},{"date":"2025-02-07","current":-0.90152,"twenty":-5.653687,"median":-3.112077,"eighty":-1.038726,"marketCap":14960889.26},{"date":"2025-02-14","current":-0.84281,"twenty":-5.653687,"median":-3.112077,"eighty":-1.033564,"marketCap":13986581.55},{"date":"2025-02-21","current":-1.130267,"twenty":-5.653687,"median":-3.112077,"eighty":-1.033463,"marketCap":18757000.3},{"date":"2025-02-28","current":-0.841171,"twenty":-5.653687,"median":-3.112077,"eighty":-1.02992,"marketCap":13959392.07},{"date":"2025-03-07","current":-0.804674,"twenty":-5.65468,"median":-3.113448,"eighty":-1.019663,"marketCap":13353720.27},{"date":"2025-03-14","current":-1.116887,"twenty":-5.65468,"median":-3.113448,"eighty":-1.014943,"marketCap":12946957.64},{"date":"2025-03-21","current":-1.426568,"twenty":-5.65468,"median":-3.113448,"eighty":-1.014943,"marketCap":16536777.66},{"date":"2025-03-28","current":-1.298977,"twenty":-5.65468,"median":-3.113448,"eighty":-1.017694,"marketCap":15057742.72},{"date":"2025-04-04","current":-1.123519,"twenty":-5.65468,"median":-3.113448,"eighty":-1.017694,"marketCap":13023828.48},{"date":"2025-04-11","current":-1.303523,"twenty":-5.653687,"median":-3.112077,"eighty":-1.019879,"marketCap":15110435.6},{"date":"2025-04-17","current":-1.424182,"twenty":-5.653687,"median":-3.112077,"eighty":-1.021386,"marketCap":16509113.2},{"date":"2025-04-25","current":-1.947061,"twenty":-5.65468,"median":-3.113448,"eighty":-1.020956,"marketCap":22570327.49},{"date":"2025-04-29","current":-1.596869,"twenty":-5.65468,"median":-3.113448,"eighty":-1.020956,"marketCap":18510901.2}],"updateTime":1746043998205}}}